OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 73 citing articles:

Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
Koen B. Pouwels, Emma Pritchard, Philippa C. Matthews, et al.
Nature Medicine (2021) Vol. 27, Iss. 12, pp. 2127-2135
Open Access | Times Cited: 531

Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines
Jia Wei, Koen B. Pouwels, Nicole Stoesser, et al.
Nature Medicine (2022) Vol. 28, Iss. 5, pp. 1072-1082
Open Access | Times Cited: 216

Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
Koen B. Pouwels, Emma Pritchard, Philippa C. Matthews, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 141

Effectiveness of Curcumin on Outcomes of Hospitalized COVID-19 Patients: A Systematic Review of Clinical Trials
Amir Vahedian‐Azimi, Mitra Abbasifard, Farshid Rahimi‐Bashar, et al.
Nutrients (2022) Vol. 14, Iss. 2, pp. 256-256
Open Access | Times Cited: 115

Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants
Angela Choi, Matthew Koch, Kaichun Wu, et al.
Journal of Virology (2021) Vol. 95, Iss. 23
Open Access | Times Cited: 110

The Emergence of Omicron: Challenging Times Are Here Again!
Tanu Singhal
The Indian Journal of Pediatrics (2022) Vol. 89, Iss. 5, pp. 490-496
Open Access | Times Cited: 98

The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far
Vivek P. Chavda, Rajashri Bezbaruah, Kangkan Deka, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1926-1926
Open Access | Times Cited: 71

Neutralizing antibody activity against 21 SARS-CoV-2 variants in older adults vaccinated with BNT162b2
Joseph Newman, Nazia Thakur, Thomas P. Peacock, et al.
Nature Microbiology (2022) Vol. 7, Iss. 8, pp. 1180-1188
Open Access | Times Cited: 64

A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant
Mengxin Zhang, Ying Liang, Dongsheng Yu, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 2, pp. 889-900
Open Access | Times Cited: 60

Risk of SARS-CoV-2 reinfections in children: a prospective national surveillance study between January, 2020, and July, 2021, in England
Anna Mensah, Helen Campbell, Julia Stowe, et al.
The Lancet Child & Adolescent Health (2022) Vol. 6, Iss. 6, pp. 384-392
Open Access | Times Cited: 47

Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines
Rupsha Fraser, Aurelio Orta‐Resendiz, Alexander Mazein, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 4, pp. 255-267
Open Access | Times Cited: 31

Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19
Roberto Lozano‐Rodríguez, Jaime Valentín‐Quiroga, José Avendaño‐Ortiz, et al.
Cell Reports (2021) Vol. 38, Iss. 2, pp. 110235-110235
Open Access | Times Cited: 46

BNT162b2-induced neutralizing and non-neutralizing antibody functions against SARS-CoV-2 diminish with age
Timothy A. Bates, Pei Lu, Ye jin Kang, et al.
Cell Reports (2022) Vol. 41, Iss. 4, pp. 111544-111544
Open Access | Times Cited: 29

Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
Yang Yang, Fang Li, Lanying Du
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6

Humoral Response to BNT162b2 Vaccine Against SARS-CoV-2 Variants Decays After Six Months
Tulio J. Lopera, Mateo Chvatal-Medina, Lizdany Flórez‐Álvarez, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26

SARS-CoV-2 and COVID-19: A Narrative Review
Andrew D. Blann, Rebekka Heitmar
British Journal of Biomedical Science (2022) Vol. 79
Open Access | Times Cited: 26

Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human Sera
Yfat Yahalom-Ronen, Noam Erez, Morly Fisher, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 291-291
Open Access | Times Cited: 23

Pathogen evolution during vaccination campaigns
Troy Day, David Kennedy, Andrew F. Read, et al.
PLoS Biology (2022) Vol. 20, Iss. 9, pp. e3001804-e3001804
Open Access | Times Cited: 22

Mitochondrial oxidative stress, mitochondrial ROS storms in long COVID pathogenesis
Kunwadee Noonong, Moragot Chatatikun, Sirirat Surinkaew, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12

Immunoregulatory effects of nanocurcumin in inflammatory milieu: Focus on COVID-19
Fahimeh Lavi Arab, Akram Hoseinzadeh, Fatemeh Mohammadi, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116131-116131
Open Access | Times Cited: 4

Natural products as a source of novel drugs for treating SARS-CoV2 infection
Ciro Isidoro, Ashley Chang, Lee‐Yan Sheen
Journal of Traditional and Complementary Medicine (2022) Vol. 12, Iss. 1, pp. 1-5
Open Access | Times Cited: 19

Effectiveness of COVID-19 Vaccines against Delta Variant (B.1.617.2): A Meta-Analysis
Rashidul Alam Mahumud, Mohammad Afshar Ali, Satyajit Kundu, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 277-277
Open Access | Times Cited: 18

RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge
Juan Shi, Jian Zheng, Xiujuan Zhang, et al.
Translational research (2022) Vol. 248, pp. 11-21
Open Access | Times Cited: 17

Page 1 - Next Page

Scroll to top